Dr. Agnes Klein is currently the Director of the Centre for the Evaluation of Radiopharmaceuticals and Biotherapeutic Products (within Health Canada's Biologics and Genetic Therapies Directorate). She received her medical degree from the University of Toronto and is trained in Endocrinology, Medical Biochemistry and Public and Community Health. Since joining Health Canada in 1974, she has held a range of scientific and management positions within the department and its regulatory arms, including having acted as the Director of the Bureau of Human Prescription Drugs and as Director for the Biologics and Genetic Therapies Evaluation Centre. From 2001 to 2004, she was the Manager (Clinical Evaluation Division) of a newly created division responsible for clinical-trial application, pre-market review and decisions regarding post-market events relating to biological/biotechnology agents. Since September 2004, Dr. Klein has served as Senior Medical Advisor and Acting Director for a newly created evaluation centre within the Biologics and Genetic Therapies Directorate. She is an active member of several medical and scientific organizations nationally and internationally.